Coeptis Therapeutics Holdings

Coeptis Therapeutics is a biopharmaceutical company developing innovative cell therapy platforms for cancer, autoimmune, and infectious diseases. Their portfolio includes assets licensed from Deverra Therapeutics and the University of Pittsburgh, focusing on disrupting conventional treatment paradigms and improving patient outcomes. Coeptis utilizes a business model centered around maximizing the value of its product portfolio through licensing agreements, co-development, and strategic partnerships.

+ 0 Upvotes
Buy Funded Startups lists